Advances in Clinical Research in Chronic Kidney Disease.
作者信息
Zou Yutong, Liu Fang, Cooper Mark E, Chai Zhonglin
机构信息
Division of Nephrology, West China Hospital of Sichuan University, Chengdu 610041, Sichuan Province, China.
Department of Diabetes, Central Clinical School, Monash University, Melbourne 3800, Australia.
出版信息
J Transl Int Med. 2021 Sep 28;9(3):146-149. doi: 10.2478/jtim-2021-0041. eCollection 2021 Sep.
Abstract
摘要
相似文献
1
Advances in Clinical Research in Chronic Kidney Disease.慢性肾脏病临床研究进展
J Transl Int Med. 2021 Sep 28;9(3):146-149. doi: 10.2478/jtim-2021-0041. eCollection 2021 Sep.
2
Translational science in chronic kidney disease.慢性肾脏病中的转化医学
Clin Sci (Lond). 2017 Jun 30;131(14):1617-1629. doi: 10.1042/CS20160395. Print 2017 Jul 15.
3
Clinical cancer advances 2006: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.2006年临床癌症进展：癌症治疗、预防及筛查方面的重大研究进展——美国临床肿瘤学会报告
J Clin Oncol. 2007 Jan 1;25(1):146-62. doi: 10.1200/JCO.2006.09.7030. Epub 2006 Dec 8.
4
Management of hyperphosphataemia of chronic kidney disease: lessons from the past and future directions.慢性肾脏病高磷血症的管理：过去的经验教训与未来方向
Nephrol Dial Transplant. 2002 Jul;17(7):1170-5. doi: 10.1093/ndt/17.7.1170.
5
Viral hepatitis infections in chronic kidney disease patients and renal transplant recipients.慢性肾脏病患者和肾移植受者的病毒性肝炎感染。
Kidney Blood Press Res. 2012;35(6):454-67. doi: 10.1159/000338309. Epub 2012 Jun 6.
6
Pharmacological management of acute kidney injury and chronic kidney disease in neonates.新生儿急性肾损伤和慢性肾脏病的药物治疗
Semin Fetal Neonatal Med. 2017 Apr;22(2):109-115. doi: 10.1016/j.siny.2016.09.002. Epub 2016 Oct 6.
7
Kidney disease in children: latest advances and remaining challenges.儿童肾脏病：最新进展与尚存挑战。
Nat Rev Nephrol. 2016 Mar;12(3):182-91. doi: 10.1038/nrneph.2015.219. Epub 2016 Feb 1.
8
Advances in the proinflammatory effects of visfatin and its relationship with diabetic kidney disease.内脂素的促炎作用进展及其与糖尿病肾病的关系
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2015 Apr;37(2):246-52. doi: 10.3881/j.issn.1000-503X.2015.02.019.
9
BMP-7 Signaling and its Critical Roles in Kidney Development, the Responses to Renal Injury, and Chronic Kidney Disease.骨形态发生蛋白-7信号传导及其在肾脏发育、肾损伤反应和慢性肾脏病中的关键作用
Vitam Horm. 2015;99:91-144. doi: 10.1016/bs.vh.2015.05.003.
10
Management of diabetic kidney disease: Recent advances.糖尿病肾病的管理：最新进展
Indian J Endocrinol Metab. 2013 Oct;17(Suppl 1):S55-8. doi: 10.4103/2230-8210.119506.
引用本文的文献
1
PAR2 activation on human tubular epithelial cells engages converging signaling pathways to induce an inflammatory and fibrotic milieu.人肾小管上皮细胞上的PAR2激活会促使信号通路汇聚，从而诱导炎性和纤维化环境。
Front Pharmacol. 2024 Jun 28;15:1382094. doi: 10.3389/fphar.2024.1382094. eCollection 2024.
2
Combined Serologic and Genetic Risk Score and Prognostication of Phospholipase A2 receptor-Associated Membranous Nephropathy.联合血清学和遗传学风险评分与磷脂酶 A2 受体相关膜性肾病的预后评估。
Clin J Am Soc Nephrol. 2024 May 1;19(5):573-582. doi: 10.2215/CJN.0000000000000422. Epub 2024 Feb 29.
3
Navigating the Crossroads: Understanding the Link Between Chronic Kidney Disease and Cardiovascular Health.探索十字路口：理解慢性肾脏病与心血管健康之间的联系
Cureus. 2023 Dec 30;15(12):e51362. doi: 10.7759/cureus.51362. eCollection 2023 Dec.
4
A Comprehensive Weighted Gene Co-expression Network Analysis Uncovers Potential Targets in Diabetic Kidney Disease.一项综合加权基因共表达网络分析揭示了糖尿病肾病的潜在靶点。
J Transl Int Med. 2023 Jan 13;10(4):359-368. doi: 10.2478/jtim-2022-0053. eCollection 2022 Dec.
5
Smartphone-Based Quantitative Analysis of Protein Array Signals for Biomarker Detection in Lupus.基于智能手机的蛋白质阵列信号定量分析用于狼疮生物标志物检测
Chemosensors (Basel). 2022 Aug;10(8). doi: 10.3390/chemosensors10080330. Epub 2022 Aug 13.
6
Dapagliflozin Ameliorates Renal Tubular Ferroptosis in Diabetes via SLC40A1 Stabilization.达格列净通过稳定 SLC40A1 减轻糖尿病肾小管铁死亡。
Oxid Med Cell Longev. 2022 Aug 10;2022:9735555. doi: 10.1155/2022/9735555. eCollection 2022.
本文引用的文献
1
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes.非奈利酮对 2 型糖尿病患者慢性肾脏病结局的影响。
N Engl J Med. 2020 Dec 3;383(23):2219-2229. doi: 10.1056/NEJMoa2025845. Epub 2020 Oct 23.
2
The cardiovascular outcomes, heart failure and kidney disease trials tell that the time to use Sodium Glucose Cotransporter 2 inhibitors is now.心血管结局、心力衰竭和肾脏病试验表明，现在是使用钠-葡萄糖共转运蛋白 2 抑制剂的时候了。
Clin Cardiol. 2020 Dec;43(12):1376-1387. doi: 10.1002/clc.23508. Epub 2020 Nov 9.
3
Dapagliflozin in Patients with Chronic Kidney Disease.达格列净治疗慢性肾脏病患者。
N Engl J Med. 2020 Oct 8;383(15):1436-1446. doi: 10.1056/NEJMoa2024816. Epub 2020 Sep 24.
4
Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?利妥昔单抗在成人微小病变性肾病和局灶节段性肾小球硬化症中的应用：已知和未知的有哪些？
Autoimmun Rev. 2020 Nov;19(11):102671. doi: 10.1016/j.autrev.2020.102671. Epub 2020 Sep 15.
5
Effects of Linagliptin on Cardiovascular and Kidney Outcomes in People With Normal and Reduced Kidney Function: Secondary Analysis of the CARMELINA Randomized Trial.林格列汀对肾功能正常和降低的人群的心血管和肾脏结局的影响：CARMELINA 随机试验的二次分析。
Diabetes Care. 2020 Aug;43(8):1803-1812. doi: 10.2337/dc20-0279. Epub 2020 May 22.
6
Antihypertensive and Renal Mechanisms of SGLT2 (Sodium-Glucose Linked Transporter 2) Inhibitors.钠-葡萄糖协同转运蛋白2（SGLT2）抑制剂的降压及肾脏作用机制
Hypertension. 2020 Apr;75(4):894-901. doi: 10.1161/HYPERTENSIONAHA.119.11684. Epub 2020 Mar 2.
7
Effects of a prolyl hydroxylase inhibitor on kidney and cardiovascular complications in a rat model of chronic kidney disease.脯氨酰羟化酶抑制剂对慢性肾脏病大鼠模型肾脏和心血管并发症的影响。
Am J Physiol Renal Physiol. 2020 Feb 1;318(2):F388-F401. doi: 10.1152/ajprenal.00419.2019. Epub 2019 Dec 16.
8
Chronic Kidney Disease Diagnosis and Management: A Review.慢性肾脏病的诊断与管理：综述。
JAMA. 2019 Oct 1;322(13):1294-1304. doi: 10.1001/jama.2019.14745.
9
Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis.罗沙司他治疗未接受透析的肾病患者的贫血。
N Engl J Med. 2019 Sep 12;381(11):1001-1010. doi: 10.1056/NEJMoa1813599. Epub 2019 Jul 24.
10
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy.利妥昔单抗或环孢素治疗膜性肾病。
N Engl J Med. 2019 Jul 4;381(1):36-46. doi: 10.1056/NEJMoa1814427.
Zotero 插件